Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The host intestinal epithelial innate immune and barrier pathways represent a complex system of physical, chemical, and cellular components that maintain gut homeostasis and protect against pathogens. The physical barrier is primarily composed of a single layer of epithelial cells connected by tight junction proteins like claudins and occludins, which regulate paracellular permeability (Nature Reviews Gastroenterology & Hepatology, 2021). The innate immune component involves pattern recognition receptors (PRRs) such as Toll-like receptors (TLRs) and NOD-like receptors (NLRs) that sense microbial signals and trigger protective responses, including the secretion of antimicrobial peptides and mucins (Frontiers in Immunology, 2020). Dysregulation of these pathways is a hallmark of inflammatory bowel diseases (IBD), where increased permeability and aberrant immune activation lead to chronic inflammation (Science, 2017). Therapeutic strategies often target specific molecules within these pathways, such as TNF-alpha or JAK kinases, to restore barrier integrity and dampen excessive immune responses (The Lancet, 2019). Emerging therapies also focus on directly enhancing barrier function through the modulation of tight junction proteins or the administration of growth factors like GLP-2 (Gastroenterology, 2022).
Modulation of cytokine signaling, inhibition of leukocyte trafficking, and reinforcement of epithelial tight junction integrity.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host intestinal epithelial innate immune and barrier pathways.